Manish A. Shah, MD, on Gastric Cancer: Results From the RAINFALL Trial

2018 Gastrointestinal Cancers Symposium

Manish A. Shah, MD, of Weill Cornell Medicine, discusses phase III study findings on cisplatin plus capecitabine or fluorouracil with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophageal junction adenocarcinoma (Abstract 5).

Aug

Today In Oncology

Cory Wiegert Named New CEO of CancerLinQ LLC

ESR1 Fusions and Metastasis in Estrogen Receptor–Positive Breast Cancer

Assay Uses Big Data to Predict Responses to Immunotherapy

FDA Grants 510(k) Clearance to SRT-100+ Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancer and Keloids

CNS Activity of EGFR Tyrosine Kinase Inhibitor in T790M-Positive Advanced NSCLC

;